Mesenchymal stem cells and platelet rich plasma in the treatment of premature ovarian insufficiency: a scoping review

Abstract Premature ovarian Insufficiency (POI) is characterized by amenorrhea, hypergonadotropic hypogonadism, estrogen deficiency, and reduced follicle counts leading to infertility under the age of 40. It occurs in 1 to 3% of women. Several therapeutic strategies have been explored in clinic for P...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jack Gemayel, Frédéric Harb, Farah Karam, Donna Tahan, Monique Younes, Yvanna Saliba, Diana Chaker, Ahmad Ibrahim, Albert Azar, Mustapha Chaaban, Alain Chebly, Khalil Akouch, Charbel Khalil
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-09-01
Serie:	Contraception and Reproductive Medicine
Soggetti:	Premature ovarian insufficiency Mesenchymal stem cells Secretome Platelet rich plasma Stem cell therapy
Accesso online:	https://doi.org/10.1186/s40834-025-00368-1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!